nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Asthenia—Floxuridine—stomach cancer	0.00742	0.00826	CcSEcCtD
Dimenhydrinate—Somnolence—Mitomycin—stomach cancer	0.00721	0.00803	CcSEcCtD
Dimenhydrinate—Diarrhoea—Floxuridine—stomach cancer	0.00707	0.00788	CcSEcCtD
Dimenhydrinate—Decreased appetite—Mitomycin—stomach cancer	0.00705	0.00786	CcSEcCtD
Dimenhydrinate—Fatigue—Mitomycin—stomach cancer	0.007	0.00779	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Mitomycin—stomach cancer	0.00669	0.00745	CcSEcCtD
Dimenhydrinate—Vomiting—Floxuridine—stomach cancer	0.00657	0.00732	CcSEcCtD
Dimenhydrinate—Irritability—Fluorouracil—stomach cancer	0.00655	0.0073	CcSEcCtD
Dimenhydrinate—Rash—Floxuridine—stomach cancer	0.00652	0.00726	CcSEcCtD
Dimenhydrinate—Dermatitis—Floxuridine—stomach cancer	0.00651	0.00725	CcSEcCtD
Dimenhydrinate—Headache—Floxuridine—stomach cancer	0.00648	0.00721	CcSEcCtD
Dimenhydrinate—Neuritis—Epirubicin—stomach cancer	0.00617	0.00687	CcSEcCtD
Dimenhydrinate—Nausea—Floxuridine—stomach cancer	0.00614	0.00684	CcSEcCtD
Dimenhydrinate—Sweating increased—Irinotecan—stomach cancer	0.00604	0.00672	CcSEcCtD
Dimenhydrinate—Asthenia—Mitomycin—stomach cancer	0.00582	0.00648	CcSEcCtD
Dimenhydrinate—Neuritis—Doxorubicin—stomach cancer	0.00571	0.00636	CcSEcCtD
Dimenhydrinate—Diarrhoea—Mitomycin—stomach cancer	0.00555	0.00618	CcSEcCtD
Dimenhydrinate—Photosensitivity—Capecitabine—stomach cancer	0.00546	0.00609	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Fluorouracil—stomach cancer	0.00542	0.00603	CcSEcCtD
Dimenhydrinate—Dizziness—Mitomycin—stomach cancer	0.00537	0.00598	CcSEcCtD
Dimenhydrinate—Haemolytic anaemia—Capecitabine—stomach cancer	0.00532	0.00592	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Fluorouracil—stomach cancer	0.00519	0.00578	CcSEcCtD
Dimenhydrinate—Vomiting—Mitomycin—stomach cancer	0.00516	0.00575	CcSEcCtD
Dimenhydrinate—Rash—Mitomycin—stomach cancer	0.00512	0.0057	CcSEcCtD
Dimenhydrinate—Dermatitis—Mitomycin—stomach cancer	0.00511	0.00569	CcSEcCtD
Dimenhydrinate—Headache—Mitomycin—stomach cancer	0.00508	0.00566	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Fluorouracil—stomach cancer	0.00494	0.0055	CcSEcCtD
Dimenhydrinate—Nausea—Mitomycin—stomach cancer	0.00482	0.00537	CcSEcCtD
Dimenhydrinate—Diplopia—Capecitabine—stomach cancer	0.0048	0.00534	CcSEcCtD
Dimenhydrinate—Irritability—Capecitabine—stomach cancer	0.00458	0.0051	CcSEcCtD
Dimenhydrinate—Urinary retention—Capecitabine—stomach cancer	0.00456	0.00508	CcSEcCtD
Dimenhydrinate—Chills—Irinotecan—stomach cancer	0.00445	0.00496	CcSEcCtD
Dimenhydrinate—Photosensitivity—Methotrexate—stomach cancer	0.00407	0.00453	CcSEcCtD
Dimenhydrinate—Sweating increased—Capecitabine—stomach cancer	0.00404	0.0045	CcSEcCtD
Dimenhydrinate—Vision blurred—Fluorouracil—stomach cancer	0.0039	0.00434	CcSEcCtD
Dimenhydrinate—Vertigo—Irinotecan—stomach cancer	0.00388	0.00432	CcSEcCtD
Dimenhydrinate—Dysuria—Capecitabine—stomach cancer	0.00388	0.00432	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—stomach cancer	0.00381	0.00424	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Capecitabine—stomach cancer	0.00379	0.00422	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Docetaxel—stomach cancer	0.00374	0.00417	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Capecitabine—stomach cancer	0.00362	0.00404	CcSEcCtD
Dimenhydrinate—Convulsion—Fluorouracil—stomach cancer	0.00358	0.00399	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Docetaxel—stomach cancer	0.00356	0.00397	CcSEcCtD
Dimenhydrinate—Confusional state—Irinotecan—stomach cancer	0.00355	0.00396	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—stomach cancer	0.00352	0.00392	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Capecitabine—stomach cancer	0.00345	0.00384	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Irinotecan—stomach cancer	0.00345	0.00384	CcSEcCtD
Dimenhydrinate—Irritability—Methotrexate—stomach cancer	0.00341	0.0038	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Irinotecan—stomach cancer	0.00341	0.00379	CcSEcCtD
Dimenhydrinate—Confusional state—Fluorouracil—stomach cancer	0.0034	0.00379	CcSEcCtD
Dimenhydrinate—Anorexia—Irinotecan—stomach cancer	0.00336	0.00374	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—stomach cancer	0.00334	0.00372	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Fluorouracil—stomach cancer	0.0033	0.00368	CcSEcCtD
Dimenhydrinate—Tachycardia—Fluorouracil—stomach cancer	0.00329	0.00367	CcSEcCtD
Dimenhydrinate—Hypotension—Irinotecan—stomach cancer	0.00329	0.00367	CcSEcCtD
Dimenhydrinate—Anorexia—Fluorouracil—stomach cancer	0.00322	0.00358	CcSEcCtD
Dimenhydrinate—Insomnia—Irinotecan—stomach cancer	0.00319	0.00355	CcSEcCtD
Dimenhydrinate—Paraesthesia—Irinotecan—stomach cancer	0.00316	0.00352	CcSEcCtD
Dimenhydrinate—Hypotension—Fluorouracil—stomach cancer	0.00315	0.00351	CcSEcCtD
Dimenhydrinate—Somnolence—Irinotecan—stomach cancer	0.00313	0.00349	CcSEcCtD
Dimenhydrinate—Dyspepsia—Irinotecan—stomach cancer	0.0031	0.00345	CcSEcCtD
Dimenhydrinate—Tinnitus—Capecitabine—stomach cancer	0.0031	0.00345	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—stomach cancer	0.00309	0.00344	CcSEcCtD
Dimenhydrinate—Chills—Docetaxel—stomach cancer	0.00308	0.00343	CcSEcCtD
Dimenhydrinate—Decreased appetite—Irinotecan—stomach cancer	0.00306	0.00341	CcSEcCtD
Dimenhydrinate—Insomnia—Fluorouracil—stomach cancer	0.00305	0.0034	CcSEcCtD
Dimenhydrinate—Fatigue—Irinotecan—stomach cancer	0.00304	0.00338	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—stomach cancer	0.00303	0.00338	CcSEcCtD
Dimenhydrinate—Constipation—Irinotecan—stomach cancer	0.00301	0.00336	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—stomach cancer	0.003	0.00334	CcSEcCtD
Dimenhydrinate—Chills—Capecitabine—stomach cancer	0.00298	0.00332	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—stomach cancer	0.00297	0.00331	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—stomach cancer	0.00293	0.00327	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Irinotecan—stomach cancer	0.0029	0.00323	CcSEcCtD
Dimenhydrinate—Dysuria—Methotrexate—stomach cancer	0.00289	0.00322	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Methotrexate—stomach cancer	0.00282	0.00314	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—stomach cancer	0.00278	0.0031	CcSEcCtD
Dimenhydrinate—Drowsiness—Methotrexate—stomach cancer	0.00275	0.00307	CcSEcCtD
Dimenhydrinate—Vision blurred—Capecitabine—stomach cancer	0.00272	0.00303	CcSEcCtD
Dimenhydrinate—Tremor—Capecitabine—stomach cancer	0.00271	0.00302	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—stomach cancer	0.0027	0.00301	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—stomach cancer	0.00268	0.00299	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—stomach cancer	0.00267	0.00297	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—stomach cancer	0.00264	0.00294	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—stomach cancer	0.00264	0.00294	CcSEcCtD
Dimenhydrinate—Vertigo—Capecitabine—stomach cancer	0.0026	0.00289	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—stomach cancer	0.00259	0.00288	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—stomach cancer	0.00258	0.00287	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Methotrexate—stomach cancer	0.00257	0.00286	CcSEcCtD
Dimenhydrinate—Palpitations—Capecitabine—stomach cancer	0.00255	0.00284	CcSEcCtD
Dimenhydrinate—Asthenia—Irinotecan—stomach cancer	0.00253	0.00282	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—stomach cancer	0.00253	0.00281	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—stomach cancer	0.0025	0.00278	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—stomach cancer	0.00249	0.00277	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—stomach cancer	0.00247	0.00275	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—stomach cancer	0.00246	0.00274	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00244	0.00272	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irinotecan—stomach cancer	0.00241	0.00269	CcSEcCtD
Dimenhydrinate—Dry mouth—Capecitabine—stomach cancer	0.00241	0.00268	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—stomach cancer	0.0024	0.00268	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—stomach cancer	0.00238	0.00266	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—stomach cancer	0.00238	0.00265	CcSEcCtD
Dimenhydrinate—Confusional state—Capecitabine—stomach cancer	0.00238	0.00265	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—stomach cancer	0.00238	0.00265	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00234	0.0026	CcSEcCtD
Dimenhydrinate—Dizziness—Irinotecan—stomach cancer	0.00233	0.0026	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—stomach cancer	0.00232	0.00259	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—stomach cancer	0.00231	0.00257	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Capecitabine—stomach cancer	0.00231	0.00257	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—stomach cancer	0.0023	0.00257	CcSEcCtD
Dimenhydrinate—Tachycardia—Capecitabine—stomach cancer	0.0023	0.00256	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Capecitabine—stomach cancer	0.00228	0.00254	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—stomach cancer	0.00228	0.00253	CcSEcCtD
Dimenhydrinate—Anorexia—Capecitabine—stomach cancer	0.00225	0.0025	CcSEcCtD
Dimenhydrinate—Vomiting—Irinotecan—stomach cancer	0.00224	0.0025	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—stomach cancer	0.00223	0.00249	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—stomach cancer	0.00222	0.00248	CcSEcCtD
Dimenhydrinate—Rash—Irinotecan—stomach cancer	0.00222	0.00247	CcSEcCtD
Dimenhydrinate—Dermatitis—Irinotecan—stomach cancer	0.00222	0.00247	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—stomach cancer	0.00222	0.00247	CcSEcCtD
Dimenhydrinate—Headache—Irinotecan—stomach cancer	0.00221	0.00246	CcSEcCtD
Dimenhydrinate—Hypotension—Capecitabine—stomach cancer	0.0022	0.00245	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—stomach cancer	0.0022	0.00245	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—stomach cancer	0.00219	0.00244	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—stomach cancer	0.00217	0.00241	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—stomach cancer	0.00216	0.0024	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—stomach cancer	0.00215	0.00239	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—stomach cancer	0.00214	0.00239	CcSEcCtD
Dimenhydrinate—Insomnia—Capecitabine—stomach cancer	0.00213	0.00238	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—stomach cancer	0.00213	0.00237	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—stomach cancer	0.00213	0.00237	CcSEcCtD
Dimenhydrinate—Paraesthesia—Capecitabine—stomach cancer	0.00212	0.00236	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—stomach cancer	0.00212	0.00236	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—stomach cancer	0.00211	0.00235	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—stomach cancer	0.0021	0.00234	CcSEcCtD
Dimenhydrinate—Nausea—Irinotecan—stomach cancer	0.00209	0.00233	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—stomach cancer	0.00208	0.00232	CcSEcCtD
Dimenhydrinate—Dyspepsia—Capecitabine—stomach cancer	0.00208	0.00231	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—stomach cancer	0.00207	0.00231	CcSEcCtD
Dimenhydrinate—Decreased appetite—Capecitabine—stomach cancer	0.00205	0.00228	CcSEcCtD
Dimenhydrinate—Fatigue—Capecitabine—stomach cancer	0.00203	0.00226	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—stomach cancer	0.00203	0.00226	CcSEcCtD
Dimenhydrinate—Constipation—Capecitabine—stomach cancer	0.00202	0.00225	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—stomach cancer	0.00201	0.00224	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—stomach cancer	0.002	0.00223	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—stomach cancer	0.002	0.00222	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—stomach cancer	0.00198	0.0022	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—stomach cancer	0.00196	0.00218	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Capecitabine—stomach cancer	0.00194	0.00216	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—stomach cancer	0.00193	0.00215	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—stomach cancer	0.00192	0.00214	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—stomach cancer	0.0019	0.00211	CcSEcCtD
Dimenhydrinate—Urticaria—Capecitabine—stomach cancer	0.00187	0.00209	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—stomach cancer	0.00186	0.00208	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—stomach cancer	0.00185	0.00206	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—stomach cancer	0.00183	0.00204	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—stomach cancer	0.00181	0.00201	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—stomach cancer	0.00181	0.00201	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—stomach cancer	0.00178	0.00198	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—stomach cancer	0.00177	0.00197	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—stomach cancer	0.00176	0.00196	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—stomach cancer	0.00175	0.00195	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—stomach cancer	0.00174	0.00194	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—stomach cancer	0.00172	0.00191	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—stomach cancer	0.00171	0.00191	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—stomach cancer	0.0017	0.00189	CcSEcCtD
Dimenhydrinate—Asthenia—Capecitabine—stomach cancer	0.00169	0.00188	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—stomach cancer	0.00168	0.00187	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—stomach cancer	0.00167	0.00186	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—stomach cancer	0.00167	0.00186	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—stomach cancer	0.00167	0.00186	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—stomach cancer	0.00166	0.00185	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—stomach cancer	0.00165	0.00183	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—stomach cancer	0.00164	0.00183	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—stomach cancer	0.00161	0.0018	CcSEcCtD
Dimenhydrinate—Diarrhoea—Capecitabine—stomach cancer	0.00161	0.0018	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—stomach cancer	0.00161	0.00179	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—stomach cancer	0.00161	0.00179	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—stomach cancer	0.0016	0.00179	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—stomach cancer	0.00159	0.00177	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—stomach cancer	0.00159	0.00177	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—stomach cancer	0.00158	0.00176	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—stomach cancer	0.00157	0.00174	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—stomach cancer	0.00156	0.00174	CcSEcCtD
Dimenhydrinate—Dizziness—Capecitabine—stomach cancer	0.00156	0.00174	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—stomach cancer	0.00155	0.00173	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—stomach cancer	0.00155	0.00172	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—stomach cancer	0.00155	0.00172	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—stomach cancer	0.00154	0.00171	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—stomach cancer	0.00154	0.00171	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—stomach cancer	0.00153	0.00171	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—stomach cancer	0.00153	0.00171	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—stomach cancer	0.00153	0.0017	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—stomach cancer	0.00153	0.0017	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—stomach cancer	0.00151	0.00169	CcSEcCtD
Dimenhydrinate—Vomiting—Capecitabine—stomach cancer	0.0015	0.00167	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—stomach cancer	0.00149	0.00166	CcSEcCtD
Dimenhydrinate—Rash—Capecitabine—stomach cancer	0.00149	0.00166	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—stomach cancer	0.00149	0.00165	CcSEcCtD
Dimenhydrinate—Dermatitis—Capecitabine—stomach cancer	0.00149	0.00165	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—stomach cancer	0.00148	0.00165	CcSEcCtD
Dimenhydrinate—Headache—Capecitabine—stomach cancer	0.00148	0.00165	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—stomach cancer	0.00148	0.00164	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—stomach cancer	0.00147	0.00164	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—stomach cancer	0.00146	0.00163	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—stomach cancer	0.00145	0.00161	CcSEcCtD
Dimenhydrinate—Nausea—Docetaxel—stomach cancer	0.00145	0.00161	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—stomach cancer	0.00145	0.00161	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—stomach cancer	0.00145	0.00161	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—stomach cancer	0.00143	0.00159	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—stomach cancer	0.00142	0.00158	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—stomach cancer	0.00142	0.00158	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—stomach cancer	0.0014	0.00156	CcSEcCtD
Dimenhydrinate—Nausea—Capecitabine—stomach cancer	0.0014	0.00156	CcSEcCtD
Dimenhydrinate—Urticaria—Methotrexate—stomach cancer	0.00139	0.00155	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—stomach cancer	0.00137	0.00153	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—stomach cancer	0.00137	0.00152	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—stomach cancer	0.00135	0.00151	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—stomach cancer	0.00135	0.00151	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—stomach cancer	0.00134	0.00149	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—stomach cancer	0.00132	0.00147	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—stomach cancer	0.00131	0.00146	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—stomach cancer	0.00131	0.00145	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—stomach cancer	0.0013	0.00145	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—stomach cancer	0.00126	0.0014	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—stomach cancer	0.00125	0.0014	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—stomach cancer	0.00121	0.00135	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—stomach cancer	0.0012	0.00134	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—stomach cancer	0.00118	0.00131	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—stomach cancer	0.00116	0.00129	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—stomach cancer	0.00112	0.00125	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—stomach cancer	0.00112	0.00124	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—stomach cancer	0.00111	0.00123	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—stomach cancer	0.00111	0.00123	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—stomach cancer	0.0011	0.00122	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—stomach cancer	0.00109	0.00121	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—stomach cancer	0.00109	0.00121	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—stomach cancer	0.00104	0.00116	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—stomach cancer	0.00104	0.00116	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—stomach cancer	0.00104	0.00116	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—stomach cancer	0.00104	0.00115	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—stomach cancer	0.00103	0.00115	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—stomach cancer	0.00103	0.00115	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—stomach cancer	0.00101	0.00112	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—stomach cancer	0.000976	0.00109	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—stomach cancer	0.000967	0.00108	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—stomach cancer	0.000959	0.00107	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—stomach cancer	0.000958	0.00107	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—stomach cancer	0.000952	0.00106	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—stomach cancer	0.000903	0.00101	CcSEcCtD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.000317	0.00311	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000314	0.00307	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000309	0.00302	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KISS1R—stomach cancer	0.000303	0.00297	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000303	0.00297	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KISS1R—stomach cancer	0.000299	0.00292	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000298	0.00292	CbGpPWpGaD
Dimenhydrinate—HRH1—IL-4 Signaling Pathway—PIK3CA—stomach cancer	0.000297	0.00291	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000294	0.00287	CbGpPWpGaD
Dimenhydrinate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	0.00029	0.00284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000289	0.00283	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—APC—stomach cancer	0.000278	0.00272	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000278	0.00272	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000273	0.00268	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.000249	0.00244	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—AGTR2—stomach cancer	0.000248	0.00243	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—F2R—stomach cancer	0.000245	0.0024	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—AGTR2—stomach cancer	0.000244	0.00239	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—F2R—stomach cancer	0.000242	0.00237	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HRH4—stomach cancer	0.000242	0.00237	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HTR1A—stomach cancer	0.000239	0.00234	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000238	0.00233	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HRH4—stomach cancer	0.000238	0.00233	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HTR1A—stomach cancer	0.000235	0.0023	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000234	0.00229	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—RHOA—stomach cancer	0.000233	0.00228	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ANXA1—stomach cancer	0.000231	0.00226	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ANXA1—stomach cancer	0.000227	0.00222	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRB1—stomach cancer	0.000224	0.00219	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRB1—stomach cancer	0.00022	0.00215	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRH4—stomach cancer	0.000219	0.00215	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000219	0.00215	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRH4—stomach cancer	0.000216	0.00211	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—KISS1—stomach cancer	0.000215	0.00211	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—KISS1—stomach cancer	0.000212	0.00207	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.000197	0.00193	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000196	0.00192	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KISS1—stomach cancer	0.000195	0.00191	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KISS1—stomach cancer	0.000192	0.00188	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.000189	0.00185	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—RGS2—stomach cancer	0.000185	0.00181	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GAST—stomach cancer	0.000185	0.00181	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000183	0.0018	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—RGS2—stomach cancer	0.000182	0.00178	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GAST—stomach cancer	0.000182	0.00178	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRB2—stomach cancer	0.000181	0.00177	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GLI3—stomach cancer	0.000179	0.00176	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KISS1R—stomach cancer	0.000179	0.00176	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRB2—stomach cancer	0.000178	0.00175	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KISS1R—stomach cancer	0.000176	0.00173	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GLI3—stomach cancer	0.000176	0.00173	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RBP1—stomach cancer	0.000171	0.00167	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RBP1—stomach cancer	0.000168	0.00165	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—RGS2—stomach cancer	0.000168	0.00165	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GAST—stomach cancer	0.000168	0.00165	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—RGS2—stomach cancer	0.000165	0.00162	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GAST—stomach cancer	0.000165	0.00162	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.00016	0.00157	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—stomach cancer	0.000157	0.00154	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—stomach cancer	0.00015	0.00147	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—stomach cancer	0.00015	0.00147	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—CXCL8—stomach cancer	0.000142	0.00139	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—stomach cancer	0.000141	0.00138	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AGTR2—stomach cancer	0.00014	0.00137	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—WWOX—stomach cancer	0.000139	0.00137	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—F2R—stomach cancer	0.000139	0.00136	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AGTR2—stomach cancer	0.000138	0.00135	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000137	0.00135	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—WWOX—stomach cancer	0.000137	0.00134	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—F2R—stomach cancer	0.000137	0.00134	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HTR1A—stomach cancer	0.000135	0.00132	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HTR1A—stomach cancer	0.000133	0.0013	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ANXA1—stomach cancer	0.00013	0.00128	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	0.00013	0.00127	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—WIF1—stomach cancer	0.00013	0.00127	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRH4—stomach cancer	0.00013	0.00127	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ANXA1—stomach cancer	0.000128	0.00126	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRH4—stomach cancer	0.000127	0.00125	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—WIF1—stomach cancer	0.000127	0.00125	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AGTR2—stomach cancer	0.000127	0.00125	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	0.000126	0.00124	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—F2R—stomach cancer	0.000126	0.00123	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AGTR2—stomach cancer	0.000125	0.00123	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRB1—stomach cancer	0.000124	0.00122	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—F2R—stomach cancer	0.000124	0.00121	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HTR1A—stomach cancer	0.000123	0.0012	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HTR1A—stomach cancer	0.000121	0.00118	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKAB1—stomach cancer	0.00012	0.00117	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000119	0.00117	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ANXA1—stomach cancer	0.000118	0.00116	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKAB1—stomach cancer	0.000118	0.00115	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ANXA1—stomach cancer	0.000117	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KISS1—stomach cancer	0.000115	0.00113	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RNF43—stomach cancer	0.000115	0.00113	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000115	0.00112	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRB1—stomach cancer	0.000115	0.00112	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KISS1—stomach cancer	0.000114	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RNF43—stomach cancer	0.000114	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000113	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000113	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000113	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRB1—stomach cancer	0.000113	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000111	0.00109	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.00011	0.00108	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000107	0.00105	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FST—stomach cancer	0.000103	0.00101	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	0.000102	0.001	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FST—stomach cancer	0.000101	0.000992	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HBEGF—stomach cancer	0.000101	0.000986	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRB2—stomach cancer	0.000101	0.000986	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RGS2—stomach cancer	9.93e-05	0.000973	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GAST—stomach cancer	9.93e-05	0.000973	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HBEGF—stomach cancer	9.91e-05	0.000971	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	9.84e-05	0.000964	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RGS2—stomach cancer	9.77e-05	0.000957	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GAST—stomach cancer	9.77e-05	0.000957	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGG—stomach cancer	9.41e-05	0.000922	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRB2—stomach cancer	9.29e-05	0.00091	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGG—stomach cancer	9.26e-05	0.000907	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRB2—stomach cancer	9.15e-05	0.000896	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	9.11e-05	0.000892	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	9.1e-05	0.000892	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKAA1—stomach cancer	9.06e-05	0.000888	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PPP2R1A—stomach cancer	8.96e-05	0.000878	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKAA1—stomach cancer	8.92e-05	0.000873	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RBP4—stomach cancer	8.75e-05	0.000857	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—CXCL8—stomach cancer	8.75e-05	0.000857	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	8.71e-05	0.000853	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RBP4—stomach cancer	8.61e-05	0.000843	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—CXCL8—stomach cancer	8.61e-05	0.000843	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGTR2—stomach cancer	7.53e-05	0.000737	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HSPB1—stomach cancer	7.53e-05	0.000737	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—F2R—stomach cancer	7.44e-05	0.000729	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—BMP2—stomach cancer	7.44e-05	0.000729	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HSPB1—stomach cancer	7.41e-05	0.000725	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGTR2—stomach cancer	7.41e-05	0.000725	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—BMP2—stomach cancer	7.32e-05	0.000717	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—F2R—stomach cancer	7.32e-05	0.000717	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKR1C3—stomach cancer	7.32e-05	0.000717	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HTR1A—stomach cancer	7.24e-05	0.00071	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	7.2e-05	0.000706	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HTR1A—stomach cancer	7.13e-05	0.000698	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	7.01e-05	0.000687	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ANXA1—stomach cancer	7e-05	0.000685	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	6.9e-05	0.000676	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ANXA1—stomach cancer	6.88e-05	0.000674	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRB1—stomach cancer	6.78e-05	0.000664	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRB1—stomach cancer	6.67e-05	0.000653	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RPS6—stomach cancer	6.47e-05	0.000634	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RPS6—stomach cancer	6.37e-05	0.000624	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PRKCB—stomach cancer	6.37e-05	0.000624	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6ST—stomach cancer	6.34e-05	0.000621	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	6.27e-05	0.000614	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	6.24e-05	0.000611	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HBEGF—stomach cancer	5.95e-05	0.000583	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HBEGF—stomach cancer	5.85e-05	0.000573	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6R—stomach cancer	5.66e-05	0.000554	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—RHOA—stomach cancer	5.63e-05	0.000551	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6R—stomach cancer	5.57e-05	0.000546	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	5.54e-05	0.000543	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRB2—stomach cancer	5.49e-05	0.000538	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRB2—stomach cancer	5.4e-05	0.000529	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	5.38e-05	0.000527	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	5.29e-05	0.000519	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—RHOA—stomach cancer	5.11e-05	0.000501	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—RHOA—stomach cancer	5.03e-05	0.000493	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SMAD4—stomach cancer	5e-05	0.000489	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	4.94e-05	0.000484	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SMAD4—stomach cancer	4.92e-05	0.000481	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	4.86e-05	0.000476	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FYN—stomach cancer	4.74e-05	0.000465	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FYN—stomach cancer	4.67e-05	0.000457	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CXCL8—stomach cancer	4.49e-05	0.00044	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGFR2—stomach cancer	4.45e-05	0.000436	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	4.42e-05	0.000433	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGFR2—stomach cancer	4.38e-05	0.000429	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IRS2—stomach cancer	4.08e-05	0.000399	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IRS2—stomach cancer	4.01e-05	0.000393	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CAV1—stomach cancer	3.95e-05	0.000387	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APOA1—stomach cancer	3.94e-05	0.000386	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CAV1—stomach cancer	3.89e-05	0.000381	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APOA1—stomach cancer	3.88e-05	0.00038	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRKCB—stomach cancer	3.76e-05	0.000369	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6ST—stomach cancer	3.75e-05	0.000367	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRKCB—stomach cancer	3.7e-05	0.000363	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6ST—stomach cancer	3.69e-05	0.000361	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APC—stomach cancer	3.6e-05	0.000353	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APC—stomach cancer	3.54e-05	0.000347	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK3—stomach cancer	3.45e-05	0.000338	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	3.39e-05	0.000332	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6R—stomach cancer	3.34e-05	0.000327	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6R—stomach cancer	3.29e-05	0.000322	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MAPK1—stomach cancer	3.28e-05	0.000321	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EGFR—stomach cancer	3.28e-05	0.000321	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	3.23e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EGFR—stomach cancer	3.23e-05	0.000316	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	3.14e-05	0.000307	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SERPINE1—stomach cancer	3.13e-05	0.000307	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KRAS—stomach cancer	3.1e-05	0.000304	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	3.09e-05	0.000302	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	3.08e-05	0.000302	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KRAS—stomach cancer	3.05e-05	0.000299	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RHOA—stomach cancer	3.02e-05	0.000296	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOS3—stomach cancer	2.99e-05	0.000293	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RHOA—stomach cancer	2.97e-05	0.000291	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOS3—stomach cancer	2.94e-05	0.000288	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	2.85e-05	0.000279	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	2.8e-05	0.000274	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ERBB2—stomach cancer	2.8e-05	0.000274	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ERBB2—stomach cancer	2.75e-05	0.000269	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL8—stomach cancer	2.65e-05	0.00026	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRAS—stomach cancer	2.63e-05	0.000258	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL8—stomach cancer	2.61e-05	0.000256	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRAS—stomach cancer	2.59e-05	0.000254	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1B—stomach cancer	2.59e-05	0.000254	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.55e-05	0.00025	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—stomach cancer	2.52e-05	0.000247	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.48e-05	0.000243	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCND1—stomach cancer	2.47e-05	0.000242	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JUN—stomach cancer	2.47e-05	0.000241	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.43e-05	0.000238	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JUN—stomach cancer	2.43e-05	0.000238	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP9—stomach cancer	2.4e-05	0.000235	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.39e-05	0.000234	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.36e-05	0.000231	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.35e-05	0.00023	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.33e-05	0.000228	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.3e-05	0.000225	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.15e-05	0.000211	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT3—stomach cancer	2.13e-05	0.000209	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.12e-05	0.000208	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.1e-05	0.000206	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.04e-05	0.0002	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2e-05	0.000196	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MYC—stomach cancer	1.98e-05	0.000194	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MYC—stomach cancer	1.95e-05	0.000191	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MAPK1—stomach cancer	1.94e-05	0.00019	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGFR—stomach cancer	1.94e-05	0.00019	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.91e-05	0.000187	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.91e-05	0.000187	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KRAS—stomach cancer	1.83e-05	0.000179	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.8e-05	0.000176	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.68e-05	0.000165	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.66e-05	0.000162	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TP53—stomach cancer	1.63e-05	0.000159	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TP53—stomach cancer	1.6e-05	0.000157	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRAS—stomach cancer	1.56e-05	0.000152	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.53e-05	0.00015	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—stomach cancer	1.49e-05	0.000146	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—stomach cancer	1.47e-05	0.000144	CbGpPWpGaD
